Clinical Laboratory Services Market Size, Share, and Trends 2024 to 2034

The global clinical laboratory services market size is estimated at USD 240.94 billion in 2025 and is predicted to reach around USD 317.14 billion by 2034, accelerating at a CAGR of 3.10% from 2025 to 2034. The North America clinical laboratory services market size was surpassed USD 86.47 billion in 2024 and is expanding at a CAGR of 3.23% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 1627
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Clinical Laboratory Services Market 

5.1. COVID-19 Landscape: Clinical Laboratory Services Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Clinical Laboratory Services Market, By Test Type

8.1. Clinical Laboratory Services Market, by Test Type Type

8.1.1. Human and Tumor Genetics

8.1.1.1. Market Revenue and Forecast

8.1.2. Clinical Chemistry

8.1.2.1. Market Revenue and Forecast

8.1.3. Medical Microbiology and Cytology

8.1.3.1. Market Revenue and Forecast

8.1.4. Genetic Testing

8.1.4.1. Market Revenue and Forecast

8.1.5. Drug of Abuse Testing

8.1.5.1. Market Revenue and Forecast

8.1.6. Other Esoteric Tests

8.1.6.1. Market Revenue and Forecast

Chapter 9. Global Clinical Laboratory Services Market, By Application

9.1. Clinical Laboratory Services Market, by Application

9.1.1. Bioanalytical and Lab Chemistry Services

9.1.1.1. Market Revenue and Forecast

9.1.2. Toxicology Testing Services

9.1.2.1. Market Revenue and Forecast

9.1.3. Cell and Gene Therapy Related Services

9.1.3.1. Market Revenue and Forecast

9.1.4. Preclinical and Clinical Trial Related Services

9.1.4.1. Market Revenue and Forecast

9.1.5. Drug Discovery and Development Related Services

9.1.5.1. Market Revenue and Forecast

9.1.6. Others

9.1.6.1. Market Revenue and Forecast

Chapter 10. Global Clinical Laboratory Services Market, By Service Provider 

10.1. Clinical Laboratory Services Market, by Service Provider

10.1.1. Hospital based laboratories

10.1.1.1. Market Revenue and Forecast

10.1.2. Standalone laboratories

10.1.2.1. Market Revenue and Forecast

10.1.3. Clinic based laboratories

10.1.3.1. Market Revenue and Forecast

Chapter 11. Global Clinical Laboratory Services Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Test Type

11.1.2. Market Revenue and Forecast, by Application

11.1.3. Market Revenue and Forecast, by Service Provider

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Test Type

11.1.4.2. Market Revenue and Forecast, by Application

11.1.4.3. Market Revenue and Forecast, by Service Provider

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Test Type

11.1.5.2. Market Revenue and Forecast, by Application

11.1.5.3. Market Revenue and Forecast, by Service Provider

11.2. Europe

11.2.1. Market Revenue and Forecast, by Test Type

11.2.2. Market Revenue and Forecast, by Application

11.2.3. Market Revenue and Forecast, by Service Provider

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Test Type

11.2.4.2. Market Revenue and Forecast, by Application

11.2.4.3. Market Revenue and Forecast, by Service Provider

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Test Type

11.2.5.2. Market Revenue and Forecast, by Application

11.2.5.3. Market Revenue and Forecast, by Service Provider

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Test Type

11.2.6.2. Market Revenue and Forecast, by Application

11.2.6.3. Market Revenue and Forecast, by Service Provider

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Test Type

11.2.7.2. Market Revenue and Forecast, by Application

11.2.7.3. Market Revenue and Forecast, by Service Provider

11.3. APAC

11.3.1. Market Revenue and Forecast, by Test Type

11.3.2. Market Revenue and Forecast, by Application

11.3.3. Market Revenue and Forecast, by Service Provider

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Test Type

11.3.4.2. Market Revenue and Forecast, by Application

11.3.4.3. Market Revenue and Forecast, by Service Provider

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Test Type

11.3.5.2. Market Revenue and Forecast, by Application

11.3.5.3. Market Revenue and Forecast, by Service Provider

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Test Type

11.3.6.2. Market Revenue and Forecast, by Application

11.3.6.3. Market Revenue and Forecast, by Service Provider

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Test Type

11.3.7.2. Market Revenue and Forecast, by Application

11.3.7.3. Market Revenue and Forecast, by Service Provider

11.4. MEA

11.4.1. Market Revenue and Forecast, by Test Type

11.4.2. Market Revenue and Forecast, by Application

11.4.3. Market Revenue and Forecast, by Service Provider

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Test Type

11.4.4.2. Market Revenue and Forecast, by Application

11.4.4.3. Market Revenue and Forecast, by Service Provider

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Test Type

11.4.5.2. Market Revenue and Forecast, by Application

11.4.5.3. Market Revenue and Forecast, by Service Provider

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Test Type

11.4.6.2. Market Revenue and Forecast, by Application

11.4.6.3. Market Revenue and Forecast, by Service Provider

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Test Type

11.4.7.2. Market Revenue and Forecast, by Application

11.4.7.3. Market Revenue and Forecast, by Service Provider

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Test Type

11.5.2. Market Revenue and Forecast, by Application

11.5.3. Market Revenue and Forecast, by Service Provider

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Test Type

11.5.4.2. Market Revenue and Forecast, by Application

11.5.4.3. Market Revenue and Forecast, by Service Provider

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Test Type

11.5.5.2. Market Revenue and Forecast, by Application

11.5.5.3. Market Revenue and Forecast, by Service Provider

Chapter 12. Company Profiles

12.1. Charles River Laboratories International Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Laboratory Corporation of America Holdings

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. NeoGenomics Laboratories Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Siemens Healthcare GmbH

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Quest Diagnostics Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Fresenius Medical Care

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Viapath Group LLP

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Almac Group

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Sonic Healthcare

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. OPKO Health Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence Research, the global clinical laboratory services market size was reached at USD 233.70 billion in 2024 and is anticipated to rake USD 317.14 billion by 2034.

The global clinical laboratory services market is expected to grow at a CAGR of 3.10% from 2025 to 2034.

The major players operating in the clinical laboratory services market are Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories Inc., Siemens Healthcare GmbH, Quest Diagnostics Inc., Fresenius Medical Care, Viapath Group LLP, Almac Group, Sonic Healthcare, and OPKO Health Inc.

The growing number of clinical trials and research and development activities in the healthcare industry are driving the global clinical laboratory services market. The rising frequency of targeted disorders around the world is one of the major factors driving the global clinical laboratory services market.

North America region will lead the global clinical laboratory services market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client